(Q44892386)

English

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

scientific article

Statements

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. (English)
Kanti Rai
Bercedis L Peterson
Vicki A Morrison
Jonathan E Kolitz
Lois Shepherd
John D Hines
Charles A Schiffer

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit